Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs Payoneer Global Inc (PAYO) Price & Performance

Centene CorpTrade
Payoneer Global IncTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs Payoneer Global Inc — how do they compare? Centene Corp trades at $66.09 (market cap $33.93B), while Payoneer Global Inc trades at $7.11 (market cap $2.40B). The key difference: Centene Corp is far larger — about 14.1× Payoneer Global Inc's market cap. Which is the better fit depends on your goals.

CNCPAYO
Market Cap
$33.93B$2.40B
Sector
HealthTechnology
52-Week High
$68.72$7.42
52-Week Low
$25.21$4.27
Enterprise Value
$26.56B$2.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

Payoneer Global Inc

Payoneer (PAYO) trades at $7.10, flat on the day, with a bullish technical signal driven by moving averages. The company reported Q1 2026 EPS of $0.06, beating expectations, but missed in Q3 and Q4 2025. Revenue grew to $821.16M in 2025, though net income fell to $73.19M. Analysts maintain a 60% buy rating with an $8.20 consensus target. Recent news highlights a $2.75B acquisition by Nuvei and expansion into India, boosting sentiment but raising fairness concerns.

Outlook is mixed: the Nuvei deal offers a near-term exit at $7.40, but growth initiatives like India expansion provide long-term potential. Risks include integration challenges, margin pressure, and shareholder litigation over acquisition terms. The stock's current price near the low target suggests limited upside unless the deal is renegotiated or standalone execution improves.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About Payoneer Global Inc

Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.

Read more on PAYO